LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/CMS Approves Ortho Association for MIPS Clinical Data Registry
Legal & Regulatory and Reimbursement

CMS Approves Ortho Association for MIPS Clinical Data Registry

January 3, 2018 2 min read Premium comments

Advertisement

CMS Approves Ortho Association for MIPS Clinical Data Registry
MIPS Payment Program / Courtesy of CMS
Secondary

Centers for Medicare and Medicaid Services (CMS) has approved the American Association of Orthopaedic Executives (AAOE) as a Qualified Clinical Data Registry (QCDR).

This is a big deal because the registry allows providers to collect the data needed to participate in the Merit-Based Incentive Payment System (MIPS) coming in 2019, and qualify for higher payments.

MIPS came out the ashes of the much-despised Sustainable Growth Rate (SGR) formula used to determine reimbursement rates for medical providers. The new reimbursement system consolidated numerous quality measurement programs so providers could be measured on quality outcomes.

Transition to MIPS

As CMS began to phase out of the Fee-for-Service (FFS) program it continued to apply a Value-Based Payment Modifier (Value Modifier) for differential payments to physicians based on the quality and cost of care they furnish to beneficiaries enrolled in the traditional Medicare Fee-for-Service program.

Under the Value Modifier, performance on quality and cost measures translated into increased payment for physicians who provide “high quality, efficient” care and decreased payment for “low-performing” physicians who underperform. The Value Modifier will expire at the end of 2018, as MIPS begins in 2019.

To prepare for 2019, the Association is touting a “truly affordable” rate to help providers measure such things as:

  • Patient Satisfaction
  • Patient Reported Outcomes
  • Quality Measures

The cost is only $100 per provider for 2018 and $200 for the following three years if you sign up by April 17, 2018. This rate includes access to one or all elements of the data warehouse, depending on your level of participation.

Advertisement

For more information on the AAOE QCDR, Data Warehouse, and Benchmarking Survey, visit www.aaoe.net/datawarehouse or contact AAOE Director, Data Solutions Vicki Sprague, Ph.D., at vsprague@aaoe.net or 317-749-0626.

AAOE President Ron Chorzewski, PT, MBA, Executive Director, Agility Orthopedics, said 19 practices and 243 providers are already participating. He added the registry “is an important addition to the resources AAOE members can use to better manage our practices and set the standard for excellence in the industry.”

In a December 27, 2017 press release, the Association said this is an important initiative of AAOE to “give back to the orthopaedic community” by providing all members, no matter their practice size, with a one-stop-shop for their data collection, benchmarking, and reporting needs.

The association was founded in 1969 as practice management association serving the orthopedic industry. Membership includes more than 1,600 orthopedic practice executives, administrators, physicians, and their staff. The association is loosely affiliated with the American Academy of Orthopaedic Surgeons (AAOS), dealing with the business side of orthopedic practices.

To study up on the MIPS program, click here.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy